These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 2969259)

  • 1. Tolerance of spironolactone.
    Hughes BR; Cunliffe WJ
    Br J Dermatol; 1988 May; 118(5):687-91. PubMed ID: 2969259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Brown J; Farquhar C; Lee O; Toomath R; Jepson RG
    Cochrane Database Syst Rev; 2009 Apr; (2):CD000194. PubMed ID: 19370553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Farquhar C; Lee O; Toomath R; Jepson R
    Cochrane Database Syst Rev; 2003; (4):CD000194. PubMed ID: 14583916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cutaneous effects in hormonal contraception].
    Thomas P; Dalle E; Revillon B; Delecour M; Devarenne-nicolle MF; Pagniez I
    NPN Med; 1985 Jan; 5(81):19-24. PubMed ID: 12281276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of spironolactone in treatment of hirsutism.
    Cumming DC
    Cleve Clin J Med; 1990 May; 57(3):285-7. PubMed ID: 2357784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Farquhar C; Lee O; Toomath R; Jepson R
    Cochrane Database Syst Rev; 2001; (4):CD000194. PubMed ID: 11687072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Lee O; Farquhar C; Toomath R; Jepson R
    Cochrane Database Syst Rev; 2000; (2):CD000194. PubMed ID: 10796700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term use of spironolactone for acne in women: A case series of 403 patients.
    Garg V; Choi JK; James WD; Barbieri JS
    J Am Acad Dermatol; 2021 May; 84(5):1348-1355. PubMed ID: 33434594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen antagonists in androgen target tissues.
    Tindall DJ; Chang CH; Lobl TJ; Cunningham GR
    Pharmacol Ther; 1984; 24(3):367-400. PubMed ID: 6205409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral and topical spironolactone therapies in skin androgenization.
    Messina M; Manieri C; Musso MC; Pastorino R
    Panminerva Med; 1990; 32(2):49-55. PubMed ID: 2147469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-androgenic therapy in young patients and its impact on intensity of hirsutism, acne, menstrual pain intensity and sexuality - a preliminary study.
    Fuchs A; Matonóg A; Sieradzka P; Pilarska J; Hauzer A; Czech I; Drosdzol-Cop A
    Ginekol Pol; 2019; 90(9):520-526. PubMed ID: 31588549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects and side-effects of spironolactone therapy in women with acne.
    Yemisci A; Gorgulu A; Piskin S
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):163-6. PubMed ID: 15752283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spironolactone in combination with an oral contraceptive: an alternative treatment for hirsutism.
    Chapman MG; Dowsett M; Dewhurst CJ; Jeffcoate SL
    Br J Obstet Gynaecol; 1985 Sep; 92(9):983-5. PubMed ID: 4041402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial.
    Cusan L; Dupont A; Gomez JL; Tremblay RR; Labrie F
    Fertil Steril; 1994 Feb; 61(2):281-7. PubMed ID: 8299783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of spironolactone in dermatology.
    Rathnayake D; Sinclair R
    Skinmed; 2010; 8(6):328-32; quiz 333. PubMed ID: 21413648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term safety of spironolactone in acne: results of an 8-year followup study.
    Shaw JC; White LE
    J Cutan Med Surg; 2002; 6(6):541-5. PubMed ID: 12219252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia.
    Burke BM; Cunliffe WJ
    Br J Dermatol; 1985 Jan; 112(1):124-5. PubMed ID: 3155956
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of sequential cyproterone acetate/estrogen versus spironolactone/oral contraceptive in the treatment of hirsutism.
    O'Brien RC; Cooper ME; Murray RM; Seeman E; Thomas AK; Jerums G
    J Clin Endocrinol Metab; 1991 May; 72(5):1008-13. PubMed ID: 1827125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
    Lemay A; Dewailly SD; Grenier R; Huard J
    J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose spironolactone in the treatment of female hirsutism.
    Ylöstalo P; Heikkinen J; Kauppila A; Pakarinen A; Järvinen PA
    Int J Fertil; 1987; 32(1):41-5. PubMed ID: 2880814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.